Table 1.
Total population* |
Very high risk† |
High risk† |
||||
---|---|---|---|---|---|---|
3 726 380 |
114 255 |
134 610 |
||||
Number | Per cent | Number | Per cent | Number | Per cent | |
Gender | ||||||
Male | 1 788 048 | 48.0 | 54 357 | 47.6 | 61 803 | 45.9 |
Female | 1 938 332 | 52.0 | 59 898 | 52.4 | 72 807 | 54.1 |
Age groups | ||||||
18–24 | 258 338 | 6.9 | 76 | 0.1 | 105 | 0.1 |
25–34 | 499 786 | 13.4 | 302 | 0.3 | 391 | 0.3 |
35–44 | 732 626 | 19.7 | 1137 | 1.0 | 1198 | 0.9 |
45–54 | 676 047 | 18.1 | 2612 | 2.3 | 2485 | 1.8 |
55–64 | 550 689 | 14.8 | 5391 | 4.7 | 5287 | 3.9 |
65–74 | 482 346 | 12.9 | 13 154 | 11.5 | 14 471 | 10.8 |
75–84 | 364 369 | 9.8 | 33 430 | 29.3 | 44 857 | 33.3 |
85+ | 162 179 | 4.4 | 58 153 | 50.9 | 65 816 | 48.9 |
Number of chronic conditions | ||||||
0–1 | 2 775 888 | 74.5 | 8176 | 7.2 | 24 618 | 18.3 |
2 or more | 950 492 | 25.5 | 106 079 | 92.8 | 109 992 | 81.7 |
5 or more | 99 337 | 2.7 | 45 445 | 39.8 | 20 576 | 15.3 |
Selected conditions/body systems | ||||||
Cancer | 99 328 | 2.7 | 23 872 | 20.9 | 14 305 | 10.6 |
Cardiovascular | 967 796 | 26.0 | 96 157 | 84.2 | 103 749 | 77.1 |
Male genitourinary‡ | 130 609 | 7.3 | 14 616 | 26.9 | 16 776 | 27.1 |
Ear, nose, throat | 5364 | 0.1 | 240 | 0.2 | 242 | 0.2 |
Endocrine | 429 528 | 11.5 | 40 653 | 35.6 | 37 471 | 27.8 |
Eye | 114 117 | 3.1 | 9,558 | 8.4 | 13 478 | 10.0 |
Gastrointestinal | 580 946 | 15.6 | 74 718 | 65.4 | 66 305 | 49.3 |
Gynaecological§ | 21 806 | 1.1 | 333 | 0.6 | 405 | 0.6 |
Haematological | 45 022 | 1.2 | 15 353 | 13.4 | 6591 | 4.9 |
Hepatobiliary | 24 785 | 0.7 | 6,477 | 5.7 | 3306 | 2.5 |
Immunological | 3281 | 0.1 | 464 | 0.4 | 273 | 0.2 |
Infectious disease | 4723 | 0.1 | 2207 | 1.9 | 727 | 0.5 |
Musculoskeletal | 419 184 | 11.2 | 43 436 | 38.0 | 41 000 | 30.5 |
Neurological | 173 751 | 4.7 | 34 494 | 30.2 | 24 838 | 18.5 |
Psychological | 291 308 | 7.8 | 43 387 | 38.0 | 33 715 | 25.0 |
Respiratory | 176 830 | 4.7 | 39 082 | 34.2 | 21 763 | 16.2 |
Skin | 28 339 | 0.8 | 7,645 | 6.7 | 3,008 | 2.2 |
Urogenital | 37 728 | 1.0 | 16 501 | 14.4 | 5,740 | 4.3 |
Polypharmacy¶ | 609 278 | 16.4 | 92 153 | 80.7 | 92 156 | 68.5 |
Any potentially inappropriate medications (age 65 years or older)** | 257 033 | 25.5 | 51 055 | 48.7 | 49 003 | 39.2 |
*Adults (age 18 or older) and alive at 31 December 2011.
†‘Very high risk’ was defined as patients with a predicted risk of hospitalisation or death in the following year of ≥25% while ‘high risk’ was defined as patients with a predicted risk of hospitalisation of 15–24%.
‡Men only.
§Women only.
¶Polypharmacy is defined as the simultaneous use of five or more active ingredients for at least 15 consecutive days.
**The list of potentially inappropriate medications can be found in ref. 11.